Nanexa

Nanexa Assets per Share

The Total Assets per Share of Nanexa (NANEXA.ST) as of Oct 23, 2026 is 0.84 SEK. In the previous year, Total Assets per Share was 0.56 SEK — a change of 50.45% (higher).

Assets per Share

0.84SEK

YoY

50.45%

Last updated:

Total Assets per Share of Nanexa is 2025 0.84 SEK. Total Assets per Share of Nanexa was 2024 0.56 SEK. It decreases by 50.45% higher compared to the previous year.

The Nanexa Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
0.17 SEK
Jan 1, 2019
0.22 SEK
Jan 1, 2020
0.33 SEK
Jan 1, 2021
1.00 SEK
Jan 1, 2022
1.03 SEK
Jan 1, 2023
0.80 SEK
Jan 1, 2024
0.56 SEK
Jan 1, 2025
0.84 SEK
The Nanexa Assets per Share history
YEARAssets per ShareYoY
0.84SEK+50.45%
0.56SEK-30.57%
0.80SEK-22.29%
1.03SEK+3.15%
1.00SEK+207.31%
0.33SEK+51.51%
0.22SEK+27.02%
0.17SEK-15.88%
0.20SEK+61.08%
0.13SEK+164.18%
0.05SEK+201.32%
0.02SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nanexa Stock analysis

What does Nanexa do? Nanexa AB develops and distributes medical nanotechnology products including PharmaShell, a drug delivery system for targeted dosing, and antifungal coating that protects medical products from fungal growth. The company also offers low-friction coating for peripheral venous catheters. Its products are sold to healthcare providers and medical device manufacturers seeking advanced solutions for drug delivery and infection prevention. Nanexa AB's revenue comes from the sale of its nanotechnology-based products to healthcare institutions and medical device companies. The firm focuses on life science R&D, targeting applications in pharmaceuticals and medical device manufacturing. Its product portfolio serves the healthcare sector by enhancing drug efficacy and protecting medical equipment from microbial contamination. The company's business model relies on selling specialized coatings and delivery systems to medical professionals and manufacturers. PharmaShell enables precise drug targeting, while antifungal and low-friction coatings address specific clinical needs in medical device usage. These products are designed to improve patient outcomes and reduce complications in medical treatments. Nanexa is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nanexa stock

Total Assets per Share of Nanexa is 0.84 SEK in 2025.

Total Assets per Share of Nanexa changed from 0.56 SEK to 0.84 SEK, representing a 50.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Nanexa since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Nanexa

All Key Metrics — Nanexa